Indi Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 11-12-2024
- Paid Up Capital ₹ 1.97 M
as on 11-12-2024
- Company Age 40 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.60 Cr
as on 11-12-2024
- Satisfied Charges ₹ 3.50 Cr
as on 11-12-2024
- Revenue -7.59%
(FY 2022)
- Profit 53.61%
(FY 2022)
- Ebitda 428.66%
(FY 2022)
- Net Worth -38.02%
(FY 2022)
- Total Assets -16.23%
(FY 2022)
About Indi Pharma
The Corporate was formerly known as Mejoral Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 1.97 M.
The company currently has active open charges totaling ₹8.60 Cr. The company has closed loans amounting to ₹3.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Cesar Menezes, Antonio Fernandes, Maria Menezes, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232GA1984PTC000556
- Company No.
000556
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jan 1984
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Goa
Industry
Company Details
- Location
Goa, Goa, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Indi Pharma?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Maria Menezes  | Managing Director | 15-Jun-2005 | Current |
| Ramakrishna Bhat | Managing Director | 30-Sep-2021 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Cesar Menezes | Director | 15-Mar-2006 | Current |
| Antonio Fernandes | Director | 30-Sep-2000 | Current |
Financial Performance of Indi Pharma.
Indi Pharma Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 7.59% decrease. The company also saw a substantial improvement in profitability, with a 53.61% increase in profit. The company's net worth observed a substantial decline by a decrease of 38.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indi Pharma?
Unlock access to Indi Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Wallace Pharmaceuticals Private LimitedActive 56 years 10 monthsCesar Menezes and Maria Menezes are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 20 Feb 2012 | ₹5.00 Cr | Open |
The Sarswat Co-Operative Bank Ltd. Creation Date: 24 Feb 2000 | ₹2.10 Cr | Open |
The Sarswat Co-Operative Bank Ltd. Creation Date: 24 Mar 1999 | ₹1.50 Cr | Open |
How Many Employees Work at Indi Pharma?
Indi Pharma has a workforce of 249 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indi Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indi Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
